About Paragon 28, Inc. 
Paragon 28, Inc.
Medical Specialties
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 41 Schemes (15.73%)
Foreign Institutions
Held by 63 Foreign Institutions (3.48%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
72 Million
(Quarterly Results - Dec 2024)
Net Profit:
-11 Million
Medical Specialties
USD 1,098 Million (Micro Cap)
NA (Loss Making)
NA
99.31%
0.59
-41.25%
8.41






